Cidofovir Inhibits Polyomavirus BK Replication in Human Renal Tubular Cells Downstream of Viral Early Gene Expression

The human polyomavirus BK (BKV) causes nephropathy and hemorrhagic cystitis in kidney and bone marrow transplant patients, respectively. The anti‐viral cidofovir (CDV) has been used in small case series but the effects on BKV replication are unclear, since polyomaviruses do not encode viral DNA poly...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of transplantation 2008-07, Vol.8 (7), p.1413-1422
Hauptverfasser: Bernhoff, E., Gutteberg, T. J., Sandvik, K., Hirsch, H. H., Rinaldo, C. H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1422
container_issue 7
container_start_page 1413
container_title American journal of transplantation
container_volume 8
creator Bernhoff, E.
Gutteberg, T. J.
Sandvik, K.
Hirsch, H. H.
Rinaldo, C. H.
description The human polyomavirus BK (BKV) causes nephropathy and hemorrhagic cystitis in kidney and bone marrow transplant patients, respectively. The anti‐viral cidofovir (CDV) has been used in small case series but the effects on BKV replication are unclear, since polyomaviruses do not encode viral DNA polymerases. We investigated the effects of CDV on BKV(Dunlop) replication in primary human renal proximal tubule epithelial cells (RPTECs). CDV inhibited the generation of viral progeny in a dose‐dependent manner yielding a 90% reduction at 40 μg/mL. Early steps such as receptor binding and entry seemed unaffected. Initial large T‐antigen transcription and expression were also unaffected, but subsequent intra‐cellular BKV DNA replication was reduced by >90%. Late viral mRNA and corresponding protein levels were also 90% reduced. In uninfected RPTECs, CDV 40 μg/mL reduced cellular DNA replication and metabolic activity by 7% and 11% in BrdU and WST‐1 assays, respectively. BKV infection increased DNA replication to 142% and metabolic activity to 116%, respectively, which were reduced by CDV 40 μg/mL to levels of uninfected untreated RPTECs. Our results show that CDV inhibits BKV DNA replication downstream of large T‐antigen expression and involves significant host cell toxicity. This should be considered in current treatment and drug development. Cidofovir treatment of BK virus‐infected human renal tubule epithelial cells resulted in inhibition of viral DNA replication and significant host cell toxicity.
doi_str_mv 10.1111/j.1600-6143.2008.02269.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19796877</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19796877</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4789-a868afcb15ce01e61192e5391b51b6684b4ab74786bb6b0bf832cbf6acbc7b363</originalsourceid><addsrcrecordid>eNqNkMFOGzEQQK2qVaHQX6h8aW9Z7HXW6z30ACElQCQQCr1aY-NVHXntYGeb5O_rJVG4di4zGr8Zjx5CmJKC5rhYFpQTMuJ0zIqSEFGQsuRNsf2ATo8PH481q07Ql5SWhNC6FOVndEJFRQln_BT1E_sS2vDXRnzr_1hl1wk_BrcLHeRen_DVPX4yK2c1rG3w2Ho86zvwuenB4UWvegcRT4xzCV-HjU_raKDDocW_bczEFKLb4RvjDZ5uV9GklNeco08tuGS-HvIZev41XUxmo_nDze3kcj7S41o0IxBcQKsVrbQh1HBKm9JUrKGqoopzMVZjUHVGuVJcEdUKVmrVctBK14pxdoZ-7PeuYnjtTVrLziadbwVvQp8kbeqGi7rOoNiDOoaUomnlKtoO4k5SIgflcikHm3IwKwfl8k253ObRb4c_etWZl_fBg-MMfD8AkDS4NoLXNh25klS8ZtXA_dxzG-vM7r8PkJd3i6Fi_wDOqZ2o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19796877</pqid></control><display><type>article</type><title>Cidofovir Inhibits Polyomavirus BK Replication in Human Renal Tubular Cells Downstream of Viral Early Gene Expression</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Bernhoff, E. ; Gutteberg, T. J. ; Sandvik, K. ; Hirsch, H. H. ; Rinaldo, C. H.</creator><creatorcontrib>Bernhoff, E. ; Gutteberg, T. J. ; Sandvik, K. ; Hirsch, H. H. ; Rinaldo, C. H.</creatorcontrib><description>The human polyomavirus BK (BKV) causes nephropathy and hemorrhagic cystitis in kidney and bone marrow transplant patients, respectively. The anti‐viral cidofovir (CDV) has been used in small case series but the effects on BKV replication are unclear, since polyomaviruses do not encode viral DNA polymerases. We investigated the effects of CDV on BKV(Dunlop) replication in primary human renal proximal tubule epithelial cells (RPTECs). CDV inhibited the generation of viral progeny in a dose‐dependent manner yielding a 90% reduction at 40 μg/mL. Early steps such as receptor binding and entry seemed unaffected. Initial large T‐antigen transcription and expression were also unaffected, but subsequent intra‐cellular BKV DNA replication was reduced by &gt;90%. Late viral mRNA and corresponding protein levels were also 90% reduced. In uninfected RPTECs, CDV 40 μg/mL reduced cellular DNA replication and metabolic activity by 7% and 11% in BrdU and WST‐1 assays, respectively. BKV infection increased DNA replication to 142% and metabolic activity to 116%, respectively, which were reduced by CDV 40 μg/mL to levels of uninfected untreated RPTECs. Our results show that CDV inhibits BKV DNA replication downstream of large T‐antigen expression and involves significant host cell toxicity. This should be considered in current treatment and drug development. Cidofovir treatment of BK virus‐infected human renal tubule epithelial cells resulted in inhibition of viral DNA replication and significant host cell toxicity.</description><identifier>ISSN: 1600-6135</identifier><identifier>EISSN: 1600-6143</identifier><identifier>DOI: 10.1111/j.1600-6143.2008.02269.x</identifier><identifier>PMID: 18510636</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Antiviral Agents - pharmacology ; Biological and medical sciences ; BK nephropathy ; BK polyoma virus ; BK virus ; BK Virus - drug effects ; BK virus allograft nephropathy ; BK virus nephritis ; bone marrow transplantation ; Bone marrow, stem cells transplantation. Graft versus host reaction ; Cells, Cultured ; Cidofovir ; Cytosine - analogs &amp; derivatives ; Cytosine - pharmacology ; Dose-Response Relationship, Drug ; Gene Expression Regulation, Viral - drug effects ; Humans ; Infectious diseases ; kidney allograft ; kidney transplantation ; Kidney Tubules, Proximal - cytology ; Kidney Tubules, Proximal - virology ; Medical sciences ; Organophosphonates - pharmacology ; Polyomavirus ; proximal tubule ; real time polymerase chain reaction (PCR) ; real time RT‐PCR ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Viral diseases ; viral infection ; viral load ; viral therapy ; Virus Replication - drug effects</subject><ispartof>American journal of transplantation, 2008-07, Vol.8 (7), p.1413-1422</ispartof><rights>2008 The Authors Journal compilation © 2008 The American Society of Transplantation and the American Society of Transplant Surgeons</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4789-a868afcb15ce01e61192e5391b51b6684b4ab74786bb6b0bf832cbf6acbc7b363</citedby><cites>FETCH-LOGICAL-c4789-a868afcb15ce01e61192e5391b51b6684b4ab74786bb6b0bf832cbf6acbc7b363</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1600-6143.2008.02269.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1600-6143.2008.02269.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20567356$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18510636$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bernhoff, E.</creatorcontrib><creatorcontrib>Gutteberg, T. J.</creatorcontrib><creatorcontrib>Sandvik, K.</creatorcontrib><creatorcontrib>Hirsch, H. H.</creatorcontrib><creatorcontrib>Rinaldo, C. H.</creatorcontrib><title>Cidofovir Inhibits Polyomavirus BK Replication in Human Renal Tubular Cells Downstream of Viral Early Gene Expression</title><title>American journal of transplantation</title><addtitle>Am J Transplant</addtitle><description>The human polyomavirus BK (BKV) causes nephropathy and hemorrhagic cystitis in kidney and bone marrow transplant patients, respectively. The anti‐viral cidofovir (CDV) has been used in small case series but the effects on BKV replication are unclear, since polyomaviruses do not encode viral DNA polymerases. We investigated the effects of CDV on BKV(Dunlop) replication in primary human renal proximal tubule epithelial cells (RPTECs). CDV inhibited the generation of viral progeny in a dose‐dependent manner yielding a 90% reduction at 40 μg/mL. Early steps such as receptor binding and entry seemed unaffected. Initial large T‐antigen transcription and expression were also unaffected, but subsequent intra‐cellular BKV DNA replication was reduced by &gt;90%. Late viral mRNA and corresponding protein levels were also 90% reduced. In uninfected RPTECs, CDV 40 μg/mL reduced cellular DNA replication and metabolic activity by 7% and 11% in BrdU and WST‐1 assays, respectively. BKV infection increased DNA replication to 142% and metabolic activity to 116%, respectively, which were reduced by CDV 40 μg/mL to levels of uninfected untreated RPTECs. Our results show that CDV inhibits BKV DNA replication downstream of large T‐antigen expression and involves significant host cell toxicity. This should be considered in current treatment and drug development. Cidofovir treatment of BK virus‐infected human renal tubule epithelial cells resulted in inhibition of viral DNA replication and significant host cell toxicity.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Antiviral Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>BK nephropathy</subject><subject>BK polyoma virus</subject><subject>BK virus</subject><subject>BK Virus - drug effects</subject><subject>BK virus allograft nephropathy</subject><subject>BK virus nephritis</subject><subject>bone marrow transplantation</subject><subject>Bone marrow, stem cells transplantation. Graft versus host reaction</subject><subject>Cells, Cultured</subject><subject>Cidofovir</subject><subject>Cytosine - analogs &amp; derivatives</subject><subject>Cytosine - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Gene Expression Regulation, Viral - drug effects</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>kidney allograft</subject><subject>kidney transplantation</subject><subject>Kidney Tubules, Proximal - cytology</subject><subject>Kidney Tubules, Proximal - virology</subject><subject>Medical sciences</subject><subject>Organophosphonates - pharmacology</subject><subject>Polyomavirus</subject><subject>proximal tubule</subject><subject>real time polymerase chain reaction (PCR)</subject><subject>real time RT‐PCR</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><subject>Viral diseases</subject><subject>viral infection</subject><subject>viral load</subject><subject>viral therapy</subject><subject>Virus Replication - drug effects</subject><issn>1600-6135</issn><issn>1600-6143</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMFOGzEQQK2qVaHQX6h8aW9Z7HXW6z30ACElQCQQCr1aY-NVHXntYGeb5O_rJVG4di4zGr8Zjx5CmJKC5rhYFpQTMuJ0zIqSEFGQsuRNsf2ATo8PH481q07Ql5SWhNC6FOVndEJFRQln_BT1E_sS2vDXRnzr_1hl1wk_BrcLHeRen_DVPX4yK2c1rG3w2Ho86zvwuenB4UWvegcRT4xzCV-HjU_raKDDocW_bczEFKLb4RvjDZ5uV9GklNeco08tuGS-HvIZev41XUxmo_nDze3kcj7S41o0IxBcQKsVrbQh1HBKm9JUrKGqoopzMVZjUHVGuVJcEdUKVmrVctBK14pxdoZ-7PeuYnjtTVrLziadbwVvQp8kbeqGi7rOoNiDOoaUomnlKtoO4k5SIgflcikHm3IwKwfl8k253ObRb4c_etWZl_fBg-MMfD8AkDS4NoLXNh25klS8ZtXA_dxzG-vM7r8PkJd3i6Fi_wDOqZ2o</recordid><startdate>200807</startdate><enddate>200807</enddate><creator>Bernhoff, E.</creator><creator>Gutteberg, T. J.</creator><creator>Sandvik, K.</creator><creator>Hirsch, H. H.</creator><creator>Rinaldo, C. H.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>200807</creationdate><title>Cidofovir Inhibits Polyomavirus BK Replication in Human Renal Tubular Cells Downstream of Viral Early Gene Expression</title><author>Bernhoff, E. ; Gutteberg, T. J. ; Sandvik, K. ; Hirsch, H. H. ; Rinaldo, C. H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4789-a868afcb15ce01e61192e5391b51b6684b4ab74786bb6b0bf832cbf6acbc7b363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Antiviral Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>BK nephropathy</topic><topic>BK polyoma virus</topic><topic>BK virus</topic><topic>BK Virus - drug effects</topic><topic>BK virus allograft nephropathy</topic><topic>BK virus nephritis</topic><topic>bone marrow transplantation</topic><topic>Bone marrow, stem cells transplantation. Graft versus host reaction</topic><topic>Cells, Cultured</topic><topic>Cidofovir</topic><topic>Cytosine - analogs &amp; derivatives</topic><topic>Cytosine - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Gene Expression Regulation, Viral - drug effects</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>kidney allograft</topic><topic>kidney transplantation</topic><topic>Kidney Tubules, Proximal - cytology</topic><topic>Kidney Tubules, Proximal - virology</topic><topic>Medical sciences</topic><topic>Organophosphonates - pharmacology</topic><topic>Polyomavirus</topic><topic>proximal tubule</topic><topic>real time polymerase chain reaction (PCR)</topic><topic>real time RT‐PCR</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><topic>Viral diseases</topic><topic>viral infection</topic><topic>viral load</topic><topic>viral therapy</topic><topic>Virus Replication - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bernhoff, E.</creatorcontrib><creatorcontrib>Gutteberg, T. J.</creatorcontrib><creatorcontrib>Sandvik, K.</creatorcontrib><creatorcontrib>Hirsch, H. H.</creatorcontrib><creatorcontrib>Rinaldo, C. H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>American journal of transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bernhoff, E.</au><au>Gutteberg, T. J.</au><au>Sandvik, K.</au><au>Hirsch, H. H.</au><au>Rinaldo, C. H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cidofovir Inhibits Polyomavirus BK Replication in Human Renal Tubular Cells Downstream of Viral Early Gene Expression</atitle><jtitle>American journal of transplantation</jtitle><addtitle>Am J Transplant</addtitle><date>2008-07</date><risdate>2008</risdate><volume>8</volume><issue>7</issue><spage>1413</spage><epage>1422</epage><pages>1413-1422</pages><issn>1600-6135</issn><eissn>1600-6143</eissn><abstract>The human polyomavirus BK (BKV) causes nephropathy and hemorrhagic cystitis in kidney and bone marrow transplant patients, respectively. The anti‐viral cidofovir (CDV) has been used in small case series but the effects on BKV replication are unclear, since polyomaviruses do not encode viral DNA polymerases. We investigated the effects of CDV on BKV(Dunlop) replication in primary human renal proximal tubule epithelial cells (RPTECs). CDV inhibited the generation of viral progeny in a dose‐dependent manner yielding a 90% reduction at 40 μg/mL. Early steps such as receptor binding and entry seemed unaffected. Initial large T‐antigen transcription and expression were also unaffected, but subsequent intra‐cellular BKV DNA replication was reduced by &gt;90%. Late viral mRNA and corresponding protein levels were also 90% reduced. In uninfected RPTECs, CDV 40 μg/mL reduced cellular DNA replication and metabolic activity by 7% and 11% in BrdU and WST‐1 assays, respectively. BKV infection increased DNA replication to 142% and metabolic activity to 116%, respectively, which were reduced by CDV 40 μg/mL to levels of uninfected untreated RPTECs. Our results show that CDV inhibits BKV DNA replication downstream of large T‐antigen expression and involves significant host cell toxicity. This should be considered in current treatment and drug development. Cidofovir treatment of BK virus‐infected human renal tubule epithelial cells resulted in inhibition of viral DNA replication and significant host cell toxicity.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>18510636</pmid><doi>10.1111/j.1600-6143.2008.02269.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1600-6135
ispartof American journal of transplantation, 2008-07, Vol.8 (7), p.1413-1422
issn 1600-6135
1600-6143
language eng
recordid cdi_proquest_miscellaneous_19796877
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Antiviral Agents - pharmacology
Biological and medical sciences
BK nephropathy
BK polyoma virus
BK virus
BK Virus - drug effects
BK virus allograft nephropathy
BK virus nephritis
bone marrow transplantation
Bone marrow, stem cells transplantation. Graft versus host reaction
Cells, Cultured
Cidofovir
Cytosine - analogs & derivatives
Cytosine - pharmacology
Dose-Response Relationship, Drug
Gene Expression Regulation, Viral - drug effects
Humans
Infectious diseases
kidney allograft
kidney transplantation
Kidney Tubules, Proximal - cytology
Kidney Tubules, Proximal - virology
Medical sciences
Organophosphonates - pharmacology
Polyomavirus
proximal tubule
real time polymerase chain reaction (PCR)
real time RT‐PCR
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Viral diseases
viral infection
viral load
viral therapy
Virus Replication - drug effects
title Cidofovir Inhibits Polyomavirus BK Replication in Human Renal Tubular Cells Downstream of Viral Early Gene Expression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T16%3A59%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cidofovir%20Inhibits%20Polyomavirus%20BK%20Replication%20in%20Human%20Renal%20Tubular%20Cells%20Downstream%20of%20Viral%20Early%20Gene%20Expression&rft.jtitle=American%20journal%20of%20transplantation&rft.au=Bernhoff,%20E.&rft.date=2008-07&rft.volume=8&rft.issue=7&rft.spage=1413&rft.epage=1422&rft.pages=1413-1422&rft.issn=1600-6135&rft.eissn=1600-6143&rft_id=info:doi/10.1111/j.1600-6143.2008.02269.x&rft_dat=%3Cproquest_cross%3E19796877%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19796877&rft_id=info:pmid/18510636&rfr_iscdi=true